FCA
HALO icon

FinTrust Capital Advisors’s Halozyme HALO Stock Holding History

FinTrust Capital Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.56K Hold
132
– – ﹤0.01% 1002
2024
Q2 		$6.91K Hold
132
– – ﹤0.01% 974
2024
Q1 		$5.37K Hold
132
– – ﹤0.01% 977
2023
Q4 		$4.88K Buy
+132
New +$4.97K ﹤0.01% 966

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

FinTrust Capital Advisors's HALO Position: Q3 2024 in Review

FinTrust Capital Advisors held its Halozyme (HALO) position steady in Q3 2024 at 132 shares worth $7.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

FinTrust Capital Advisors first reported a position in HALO in Q4 2023 and has held it in 4 quarters since. 508 funds tracked by Wall St. Rank hold HALO as of Q3 2024.

  • FinTrust Capital Advisors held 132 shares of Halozyme worth $7.56K as of Q3 2024.
  • FinTrust Capital Advisors left its Halozyme share count unchanged in Q3 2024.
  • Halozyme made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1002 holding.
  • FinTrust Capital Advisors first reported a position in Halozyme in Q4 2023 and has held it in 4 quarters since.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.